Online Journal
IF値: 1.878(2021年)→1.8(2022年)


Journal of Medical Ultrasonics

にて英文誌のFull textを閲覧することができます.


1998 - Vol.25

Vol.25 No.05

Original Article(原著)

(0625 - 0631)


Noninvasive Evaluation of Cardiomyopathy by Measuring Thickness Change in Local Myocardium

杉村 公史郎1, 金井 浩1, 中鉢 憲賢1, 2, 塚原 保夫1, 3, 小岩 喜郎1, 4, 鎌田 英一1, 4, 手塚 文明1, 5

Kohshiro SUGIMURA1, Hiroshi KANAI1, Noriyoshi CHUBACHI1, 2, Yasuo TSUKAHARA1, 3, Yoshiro KOIWA1, 4, Hideichi KAMADA1, 4, Fumiaki TEZUKA1, 5

1東北大学大学院工学研究科電気・通信工学専攻, 2東北学院大学工学部電気工学科, 3東北大学大学院情報科学研究科, 4東北大学医学部第一内科, 5国立仙台病院臨床研究部

1Department of Electrical Engineering Graduate School of Engineering, Tohoku University, 2Department of Electrical Engineering Faculty of Engineering, Tohoku Gakuin University, 3Graduate School of Information Sciences Tohoku University, 4First Department of Internal Medicine Tohoku University School of Medicine, 5Department of Pathology Sendai National Hospital Medical Research Division

キーワード : Doxorubicin cardiomyopathy, Heart wall vibration, Local myocardial thickening, Phased tracking, Ultrasonic transcutaneous measurement

In order to diagnose heart disease, we have developed a method for transcutaneously measuring and analyzing small velocity signals of the heart wall using ultrasound and conducted experiments in vivo clearly showing differences between results obtained from healthy human subjects and those obtained from patients with serious cases of doxorubicin cardiomyopathy. It is necessary to investigate the relationship between the above results obtained by noninvasive measurement and the pathological findings from actual myocardial tissue. Because it is highly invasive and imposes a high load, however, repeated biopsy in human patients is difficult. In this study, therefore, small velocity signals on both sides of the interventricular septum (IVS) were measured noninvasively, and change in thickness of the IVS during one cardiac cycle was evaluated for healthy rabbits (controls) (n=5) and rabbits with drug-induced cardiomyopathy after administration of anthracycline carcinostatic for periods of about 5 (n=3) and 10 weeks (n=2). The experimental results confirmed that average ratio of maximum change in thickness of the IVS during one cardiac cycle to thickness at the time of R-wave (ECG) decreased from 1/4 for controls to 1/8 for those medicated for about 10-weeks as total dose of anthracycline carcinostatic was increased. On the other hand, average percent damage of myocardial tissue in the IVS increased from 0.1% in the controls to 38.7% for the 10-week group. We therefore conclude that there is clear a relationship between measurement results obtained using ultrasound and the pathological findings.